Document Detail


Antifibrinolytic agents in subarachnoid haemorrhage.
MedLine Citation:
PMID:  3546604     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
For many years clinicians have used antifibrinolytic agents to try to reduce rebleeding after subarachnoid haemorrhage. Early studies of their effectiveness produced conflicting results. This paper re-evaluates the available trials and considers benefits in the light of potential complications. Present evidence conclusively demonstrates that epsilon-aminocaproic acid and tranexamic acid administered in standard dosage, reduce the risk of rebleeding but, as a result of an increased incidence of ischaemic complications, do not benefit patients' outcome.
Authors:
K W Lindsay
Related Documents :
23728324 - Physico-chemical characterisation of the fat from red-skin rambutan (nephellium lappace...
8968454 - Increased serum lithium concentration secondary to treatment with tiaprofenic acid and ...
8937454 - Inhibition of carnitine biosynthesis by valproic acid in rats--the biochemical mechanis...
11255794 - Collaborative study on rat sperm motion analysis using cellsoft series 4000 semen analy...
10419184 - New products from the agri-food industry: the return of n-3 fatty acids into the food s...
11901104 - Predicting evolutionary potential: in vitro evolution accurately reproduces natural evo...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Journal of neurology     Volume:  234     ISSN:  0340-5354     ISO Abbreviation:  J. Neurol.     Publication Date:  1987 Jan 
Date Detail:
Created Date:  1987-04-14     Completed Date:  1987-04-14     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  0423161     Medline TA:  J Neurol     Country:  GERMANY, WEST    
Other Details:
Languages:  eng     Pagination:  1-8     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antifibrinolytic Agents / therapeutic use*
Humans
Subarachnoid Hemorrhage / drug therapy*
Chemical
Reg. No./Substance:
0/Antifibrinolytic Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Vesicle-containing dendrites in the nucleus raphe dorsalis of the cat. A serial section electron mic...
Next Document:  A controlled trial of isoniazid therapy for action tremor in multiple sclerosis.